Steven E McKenzie Selected Research

Steven E McKenzie Research Topics

Disease

23	Thrombocytopenia (Thrombopenia) 10/2023 - 09/2002
22	Thrombosis (Thrombus) 01/2024 - 09/2002
8	Hemorrhage 03/2024 - 12/2003
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 12/2020
3	Inflammation (Inflammations) 01/2018 - 10/2005
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2011 - 12/2003
2	Carotid Artery Injuries 03/2024 - 12/2023
2	Pulmonary Embolism 01/2024 - 01/2022
2	Vascular System Injuries 12/2022 - 03/2013
2	Sepsis (Septicemia) 01/2021 - 10/2014
2	COVID-19 01/2021 - 01/2021
2	Shock 11/2020 - 01/2018
2	Autoimmune Diseases (Autoimmune Disease) 02/2007 - 10/2005
1	Hypertension (High Blood Pressure) 12/2023
1	Pre-Eclampsia (Preeclampsia) 12/2023
1	Obesity 12/2023
1	Drug-Related Side Effects and Adverse Reactions 10/2023
1	Stroke (Strokes) 01/2023
1	Thromboinflammation 01/2021
1	Thrombophilia 01/2019
1	Hemolysis 01/2014
1	Anemia 01/2014
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2014
1	Vascular Diseases (Vascular Disease) 02/2007
1	Experimental Arthritis 10/2005
1	Pneumonia (Pneumonitis) 10/2005
1	Glomerulonephritis 10/2005
1	Arthritis (Polyarthritis) 10/2005
1	Hemolytic Anemia 07/2005

Drug/Important Bio-Agent (IBA)

20	Heparin (Liquaemin)FDA LinkGeneric 10/2023 - 09/2002
9	AntibodiesIBA 01/2019 - 09/2002
7	Antigen-Antibody Complex (Immune Complex)IBA 10/2023 - 10/2005
7	Platelet Factor 4IBA 01/2019 - 09/2002
6	Thrombin FDA Link 01/2024 - 04/2004
5	AutoantibodiesIBA 01/2021 - 12/2003
5	Immunoglobulin G (IgG)IBA 01/2021 - 02/2007
3	AntigensIBA 01/2021 - 02/2007
3	Fc Receptors (Fc Receptor)IBA 01/2021 - 12/2015
3	Fibrinogen (Factor I)FDA Link 11/2020 - 03/2013
3	Inosine Triphosphate (ITP)IBA 01/2011 - 12/2003
3	Fc gamma receptor IIAIBA 10/2005 - 09/2002
2	ferric chlorideIBA 03/2024 - 12/2023
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2023 - 01/2023
2	FibrinIBA 10/2023 - 03/2013
2	AnticoagulantsIBA 10/2023 - 12/2016
2	AutoantigensIBA 01/2021 - 02/2007
2	IntegrinsIBA 01/2016 - 03/2013
1	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 12/2023
1	Ad26COVS1IBA 10/2023
1	COVID-19 VaccinesIBA 10/2023
1	P-SelectinIBA 01/2023
1	TicagrelorIBA 01/2023
1	Adenosine Diphosphate (ADP)IBA 01/2022
1	Adenosine (Adenocard)FDA LinkGeneric 01/2022
1	NADPH Oxidases (NAD(P)H oxidase)IBA 12/2021
1	NADPH Oxidase 2IBA 12/2021
1	NADP (NADPH)IBA 12/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2021
1	argatroban (MPQA)FDA Link 01/2021
1	ChAdOx1 nCoV-19IBA 01/2021
1	VaccinesIBA 01/2021
1	Fondaparinux (Arixtra)FDA Link 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	MAP Kinase Kinase Kinase 5IBA 11/2020
1	Hemostatics (Antihemorrhagics)IBA 01/2020
1	polyanionsIBA 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 01/2019
1	LigandsIBA 01/2018
1	Serotonin (5 Hydroxytryptamine)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 12/2016
1	UbiquitinIBA 12/2016
1	Protein Kinase CIBA 12/2014
1	OxylipinsIBA 10/2014
1	EnzymesIBA 10/2014
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2014
1	Erythropoietin FDA Link 01/2014
1	Hemoglobins (Hemoglobin)IBA 01/2014
1	Tyrosine (L-Tyrosine)FDA Link 03/2013
1	Phospholipases (Phospholipase)IBA 03/2013
1	CollagenIBA 03/2013
1	Glycoproteins (Glycoprotein)IBA 07/2011
1	2- (2- aminocyclohexylamino)- 4- (m- tolylamino)pyrimidine- 5- carboxamideIBA 02/2011
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2011
1	Monoclonal AntibodiesIBA 01/2011
1	Imatinib Mesylate (Gleevec)FDA Link 08/2009
1	Phosphotransferases (Kinase)IBA 08/2009
1	Dasatinib (BMS 354825)FDA Link 08/2009
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 08/2009
1	Protamines (Protamine Sulfate)FDA Link 02/2007
1	CholesterolIBA 02/2007
1	CytokinesIBA 10/2005
1	Collagen Type II (Type II Collagen)IBA 10/2005
1	AntithrombinsIBA 04/2004
1	Biomarkers (Surrogate Marker)IBA 04/2004
1	Prothrombin (Factor II)IBA 04/2004
1	Antiviral Agents (Antivirals)IBA 12/2003

Therapy/Procedure

7	Therapeutics 05/2023 - 12/2003
1	Patient Readmission 01/2023
1	Lasers (Laser) 01/2022
1	Catheters 04/2004